From obesity to diabetes and cancer: epidemiological links and role of therapies
about
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesRetail Environments as a Venue for Obesity Prevention.Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: a mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasisAn epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.Residential Proximity to Major Roadways and Risk of Type 2 Diabetes Mellitus: A Meta-Analysis.Cancer Prevention: Lessons Learned and Future Directions.Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.Higher body mass index in 16-19 year-old Jewish Adolescents of North African, Middle Eastern and European Origins is a Predictor of Acute Myeloid Leukemia: a cohort of 2.3 million Israelis.IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.Hyperglycaemia is associated with cancer-related but not non-cancer-related deaths: evidence from the IPC cohort.Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha.High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells.Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.Pleiotropic Effects of Metformin on Cancer
P2860
Q30234898-E8EF05C3-84D8-4119-9520-E95043B9B67EQ30387163-54C0E5BA-9643-4081-956F-8A65DFD91576Q33761997-C61C9693-5CB8-4D43-A109-A213BA672DD6Q37553115-5001A0B8-F88D-45B0-AE36-C849AEA28654Q37628673-BB35E302-DDB8-476E-8CB3-09160662155DQ38652183-DAD0CF8A-99E2-4D38-BD85-9931552970F1Q38828407-78D686A3-BB1B-4ADF-94C6-139BEE4EC02CQ38829871-C4DEECEE-97F1-4BAE-B691-2EE8FE0423A9Q38930269-427706CF-F22F-423D-9F6A-731C7D38C6E4Q41559661-5B594E62-BFC2-45F8-B85B-D23C3EDD50EBQ47137580-C92557C7-53BD-4CD9-B0B1-61B4396EAB94Q47203381-9C5F0661-8CCF-4046-B864-AF204E1D1050Q47826406-F1774E7A-C772-4326-8559-23ADAB1EBC9CQ48318594-866BA4A3-891E-4C13-8643-99941180122CQ49973501-BCAF9218-3589-4282-B60A-BC53273E0B7EQ55048037-D2113828-4460-4284-AB56-0D8DDC3F042FQ55259443-18D7CCAB-49B7-4CEE-93BB-B8DF8650BCF1Q59138314-D87F4D97-F6F9-43A8-BEB6-0089280B9415
P2860
From obesity to diabetes and cancer: epidemiological links and role of therapies
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
From obesity to diabetes and cancer: epidemiological links and role of therapies
@ast
From obesity to diabetes and cancer: epidemiological links and role of therapies
@en
From obesity to diabetes and cancer: epidemiological links and role of therapies
@nl
type
label
From obesity to diabetes and cancer: epidemiological links and role of therapies
@ast
From obesity to diabetes and cancer: epidemiological links and role of therapies
@en
From obesity to diabetes and cancer: epidemiological links and role of therapies
@nl
prefLabel
From obesity to diabetes and cancer: epidemiological links and role of therapies
@ast
From obesity to diabetes and cancer: epidemiological links and role of therapies
@en
From obesity to diabetes and cancer: epidemiological links and role of therapies
@nl
P2093
P2860
P921
P356
P1476
From obesity to diabetes and cancer: epidemiological links and role of therapies
@en
P2093
Ana Chocarro-Calvo
Angel Castaño
Custodia García-Jiménez
María Gutiérrez-Salmerón
P2860
P2888
P304
P356
10.1038/BJC.2016.37
P407
P5008
P577
2016-02-23T00:00:00Z
P5875
P6179
1042291957